Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 161

1.

Predictive utility of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in intraductal papillary neoplasm of the bile duct.

Luvira V, Kamsa-Ard S, Pugkhem A, Luvira V, Srisuk T, Titapun A, Silsirivanit A, Wongkham S, Khuntikeo N, Pairojkul C, Bhudhisawasdi V.

Clin Exp Hepatol. 2019 Sep;5(3):250-255. doi: 10.5114/ceh.2019.87641. Epub 2019 Sep 5.

2.

Discovery of Serotransferrin Glycoforms: Novel Markers for Diagnosis of Liver Periductal Fibrosis and Prediction of Cholangiocarcinoma.

Jamnongkan W, Lebrilla CB, Barboza M, Techasen A, Loilome W, Sithithaworn P, Khuntikeo N, Pairojkul C, Chamadol N, Thanan R, Yongvanit P.

Biomolecules. 2019 Sep 27;9(10). pii: E538. doi: 10.3390/biom9100538.

3.

Opisthorchis viverrini Infection Augments the Severity of Nonalcoholic Fatty Liver Disease in High-Fat/High-Fructose Diet-Fed Hamsters.

Chaidee A, Onsurathum S, Intuyod K, Haonon O, Pannangpetch P, Pongchaiyakul C, Pinlaor P, Pairojkul C, Welbat JU, Ittiprasert W, Cochran CJ, Mann VH, Brindley PJ, Pinlaor S.

Am J Trop Med Hyg. 2019 Sep 3. doi: 10.4269/ajtmh.19-0442. [Epub ahead of print]

PMID:
31482785
5.

Establishment of Highly Transplantable Cholangiocarcinoma Cell Lines from a Patient-Derived Xenograft Mouse Model.

Vaeteewoottacharn K, Pairojkul C, Kariya R, Muisuk K, Imtawil K, Chamgramol Y, Bhudhisawasdi V, Khuntikeo N, Pugkhem A, Saeseow OT, Silsirivanit A, Wongkham C, Wongkham S, Okada S.

Cells. 2019 May 23;8(5). pii: E496. doi: 10.3390/cells8050496.

6.

Dependency of Cholangiocarcinoma on Cyclin D-Dependent Kinase Activity.

Sittithumcharee G, Suppramote O, Vaeteewoottacharn K, Sirisuksakun C, Jamnongsong S, Laphanuwat P, Suntiparpluacha M, Matha A, Chusorn P, Buraphat P, Kakanaporn C, Charngkaew K, Silsirivanit A, Korphaisarn K, Limsrichamrern S, Tripatara P, Pairojkul C, Wongkham S, Sampattavanich S, Okada S, Jirawatnotai S.

Hepatology. 2019 May 11. doi: 10.1002/hep.30704. [Epub ahead of print]

PMID:
31077409
7.

FOXM1 modulates 5-fluorouracil sensitivity in cholangiocarcinoma through thymidylate synthase (TYMS): implications of FOXM1-TYMS axis uncoupling in 5-FU resistance.

Intuyod K, Saavedra-García P, Zona S, Lai CF, Jiramongkol Y, Vaeteewoottacharn K, Pairojkul C, Yao S, Yong JS, Trakansuebkul S, Waraasawapati S, Luvira V, Wongkham S, Pinlaor S, Lam EW.

Cell Death Dis. 2018 Dec 11;9(12):1185. doi: 10.1038/s41419-018-1235-0.

8.

Discovering proteins for chemoprevention and chemotherapy by curcumin in liver fluke infection-induced bile duct cancer.

Khoontawad J, Intuyod K, Rucksaken R, Hongsrichan N, Pairojkul C, Pinlaor P, Boonmars T, Wongkham C, Jones A, Plieskatt J, Potriquet J, Bethony JM, Mulvenna J, Pinlaor S.

PLoS One. 2018 Nov 15;13(11):e0207405. doi: 10.1371/journal.pone.0207405. eCollection 2018.

9.

Attenuation of CD47-SIRPα Signal in Cholangiocarcinoma Potentiates Tumor-Associated Macrophage-Mediated Phagocytosis and Suppresses Intrahepatic Metastasis.

Vaeteewoottacharn K, Kariya R, Pothipan P, Fujikawa S, Pairojkul C, Waraasawapati S, Kuwahara K, Wongkham C, Wongkham S, Okada S.

Transl Oncol. 2019 Feb;12(2):217-225. doi: 10.1016/j.tranon.2018.10.007. Epub 2018 Nov 9.

10.

Association between Repeated Praziquantel treatment and Papillary, and Intrahepatic Cholangiocarcinoma.

Luvira V, Kamsa-Ard S, Kamsa-Ard S, Luvira V, Srisuk T, Pugkhem A, Pairojkul C, Bhudhisawasdi V.

Ann Hepatol. 2018 Aug 24;17(5):802-809. doi: 10.5604/01.3001.0012.3140.

11.

Cholangiocarcinoma Trends, Incidence, and Relative Survival in Khon Kaen, Thailand From 1989 Through 2013: A Population-Based Cancer Registry Study.

Kamsa-Ard S, Luvira V, Suwanrungruang K, Kamsa-Ard S, Luvira V, Santong C, Srisuk T, Pugkhem A, Bhudhisawasdi V, Pairojkul C.

J Epidemiol. 2019 May 5;29(5):197-204. doi: 10.2188/jea.JE20180007. Epub 2018 Aug 4.

12.

Co-occurrence of opisthorchiasis and diabetes exacerbates morbidity of the hepatobiliary tract disease.

Chaidee A, Onsurathum S, Intuyod K, Pannangpetch P, Pongchaiyakul C, Pinlaor P, Pairojkul C, Ittiprasert W, Cochran CJ, Mann VH, Brindley PJ, Pinlaor S.

PLoS Negl Trop Dis. 2018 Jun 28;12(6):e0006611. doi: 10.1371/journal.pntd.0006611. eCollection 2018 Jun.

13.

O-GlcNAcylation mediates metastasis of cholangiocarcinoma through FOXO3 and MAN1A1.

Phoomak C, Silsirivanit A, Park D, Sawanyawisuth K, Vaeteewoottacharn K, Wongkham C, Lam EW, Pairojkul C, Lebrilla CB, Wongkham S.

Oncogene. 2018 Oct;37(42):5648-5665. doi: 10.1038/s41388-018-0366-1. Epub 2018 Jun 18.

14.

Proteomics detection of S100A6 in tumor tissue interstitial fluid and evaluation of its potential as a biomarker of cholangiocarcinoma.

Onsurathum S, Haonon O, Pinlaor P, Pairojkul C, Khuntikeo N, Thanan R, Roytrakul S, Pinlaor S.

Tumour Biol. 2018 Apr;40(4):1010428318767195. doi: 10.1177/1010428318767195.

PMID:
29629840
15.

Anthocyanin complex exerts anti-cholangiocarcinoma activities and improves the efficacy of drug treatment in a gemcitabine-resistant cell line.

Intuyod K, Priprem A, Pairojkul C, Hahnvajanawong C, Vaeteewoottacharn K, Pinlaor P, Pinlaor S.

Int J Oncol. 2018 Mar 7. doi: 10.3892/ijo.2018.4306. [Epub ahead of print]

PMID:
29512768
16.

The microRNA-15a-PAI-2 axis in cholangiocarcinoma-associated fibroblasts promotes migration of cancer cells.

Utaijaratrasmi P, Vaeteewoottacharn K, Tsunematsu T, Jamjantra P, Wongkham S, Pairojkul C, Khuntikeo N, Ishimaru N, Sirivatanauksorn Y, Pongpaibul A, Thuwajit P, Thuwajit C, Kudo Y.

Mol Cancer. 2018 Jan 18;17(1):10. doi: 10.1186/s12943-018-0760-x.

17.

Clinical significance of GalNAcylated glycans in cholangiocarcinoma: Values for diagnosis and prognosis.

Saentaweesuk W, Silsirivanit A, Vaeteewoottacharn K, Sawanyawisuth K, Pairojkul C, Cha'on U, Indramanee S, Pinlaor S, Boonmars T, Araki N, Wongkham C.

Clin Chim Acta. 2018 Feb;477:66-71. doi: 10.1016/j.cca.2017.12.005. Epub 2017 Dec 5.

PMID:
29217428
18.

Papillomatosis of the Biliary Tree and Gallbladder: Successful Treatment With Repeated Resection and Liver Transplant.

Luvira V, Pugkhem A, Bhudhisawasdi V, Uttaravichien TU, Sripanuskul A, Pongskul J, Pairojkul C.

Exp Clin Transplant. 2019 Oct;17(5):688-691. doi: 10.6002/ect.2017.0121. Epub 2017 Dec 5.

19.

Prolonged oxidative stress down-regulates Early B cell factor 1 with inhibition of its tumor suppressive function against cholangiocarcinoma genesis.

Armartmuntree N, Murata M, Techasen A, Yongvanit P, Loilome W, Namwat N, Pairojkul C, Sakonsinsiri C, Pinlaor S, Thanan R.

Redox Biol. 2018 Apr;14:637-644. doi: 10.1016/j.redox.2017.11.011. Epub 2017 Nov 13.

20.

Establishment of cholangiocarcinoma cell lines from patients in the endemic area of liver fluke infection in Thailand.

Saensa-Ard S, Leuangwattanawanit S, Senggunprai L, Namwat N, Kongpetch S, Chamgramol Y, Loilome W, Khansaard W, Jusakul A, Prawan A, Pairojkul C, Khantikeo N, Yongvanit P, Kukongviriyapan V.

Tumour Biol. 2017 Nov;39(11):1010428317725925. doi: 10.1177/1010428317725925.

PMID:
29110582
21.

Subsets of Inflammatory Cytokine Gene Polymorphisms are Associated with Risk of Carcinogenic Liver Fluke Opisthorchis viverrini-Associated Advanced Periductal Fibrosis and Cholangiocarcinoma.

Surapaitoon A, Suttiprapa S, Mairiang E, Khuntikeo N, Pairojkul C, Bethony J, Brindley PJ, Sripa B.

Korean J Parasitol. 2017 Jun;55(3):295-304. doi: 10.3347/kjp.2017.55.3.295. Epub 2017 Jun 30.

22.

Clustering of patients with intrahepatic cholangiocarcinoma based on serum periostin may be predictive of prognosis.

Thuwajit C, Thuwajit P, Jamjantra P, Pairojkul C, Wongkham S, Bhudhisawasdi V, Ono J, Ohta S, Fujimoto K, Izuhara K.

Oncol Lett. 2017 Jul;14(1):623-634. doi: 10.3892/ol.2017.6250. Epub 2017 May 25.

23.

Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma.

Jusakul A, Cutcutache I, Yong CH, Lim JQ, Huang MN, Padmanabhan N, Nellore V, Kongpetch S, Ng AWT, Ng LM, Choo SP, Myint SS, Thanan R, Nagarajan S, Lim WK, Ng CCY, Boot A, Liu M, Ong CK, Rajasegaran V, Lie S, Lim AST, Lim TH, Tan J, Loh JL, McPherson JR, Khuntikeo N, Bhudhisawasdi V, Yongvanit P, Wongkham S, Totoki Y, Nakamura H, Arai Y, Yamasaki S, Chow PK, Chung AYF, Ooi LLPJ, Lim KH, Dima S, Duda DG, Popescu I, Broet P, Hsieh SY, Yu MC, Scarpa A, Lai J, Luo DX, Carvalho AL, Vettore AL, Rhee H, Park YN, Alexandrov LB, Gordân R, Rozen SG, Shibata T, Pairojkul C, Teh BT, Tan P.

Cancer Discov. 2017 Oct;7(10):1116-1135. doi: 10.1158/2159-8290.CD-17-0368. Epub 2017 Jun 30.

24.

Common Molecular Subtypes Among Asian Hepatocellular Carcinoma and Cholangiocarcinoma.

Chaisaingmongkol J, Budhu A, Dang H, Rabibhadana S, Pupacdi B, Kwon SM, Forgues M, Pomyen Y, Bhudhisawasdi V, Lertprasertsuke N, Chotirosniramit A, Pairojkul C, Auewarakul CU, Sricharunrat T, Phornphutkul K, Sangrajrang S, Cam M, He P, Hewitt SM, Ylaya K, Wu X, Andersen JB, Thorgeirsson SS, Waterfall JJ, Zhu YJ, Walling J, Stevenson HS, Edelman D, Meltzer PS, Loffredo CA, Hama N, Shibata T, Wiltrout RH, Harris CC, Mahidol C, Ruchirawat M, Wang XW; TIGER-LC Consortium.

Cancer Cell. 2017 Jul 10;32(1):57-70.e3. doi: 10.1016/j.ccell.2017.05.009. Epub 2017 Jun 22.

25.

A comparative proteomic analysis of bile for biomarkers of cholangiocarcinoma.

Laohaviroj M, Potriquet J, Jia X, Suttiprapa S, Chamgramol Y, Pairojkul C, Sithithaworn P, Mulvenna J, Sripa B.

Tumour Biol. 2017 Jun;39(6):1010428317705764. doi: 10.1177/1010428317705764.

PMID:
28618946
26.

Prognostic Factors for Large Symptomatic Gists: a Pragmatic Study of Experiences From a University Hospital Over 10 Years

Prasertcharoensuk S, Thanapongpornthana P, Bhudhisawasdi V, Pugkhem A, Jenwitheesuk K, Sookprasert A, Pairojkul Ch.

Asian Pac J Cancer Prev. 2017 Mar 1;18(3):655-658.

27.

Morphological Classification of Intraductal Papillary Neoplasm of the Bile Duct with Survival Correlation

Luvira V, Somsap K, Pugkhem A, Eurboonyanun Ch, Luvira V, Bhudhisawasdi V, Pairojkul Ch, Kamsa Ard S.

Asian Pac J Cancer Prev. 2017 Jan 1;18(1):207-213.

28.

Differential Protein Expression Marks the Transition From Infection With Opisthorchis viverrini to Cholangiocarcinoma.

Khoontawad J, Pairojkul C, Rucksaken R, Pinlaor P, Wongkham C, Yongvanit P, Pugkhem A, Jones A, Plieskatt J, Potriquet J, Bethony J, Pinlaor S, Mulvenna J.

Mol Cell Proteomics. 2017 May;16(5):911-923. doi: 10.1074/mcp.M116.064576. Epub 2017 Feb 23.

29.

Elevated prevalence of Helicobacter species and virulence factors in opisthorchiasis and associated hepatobiliary disease.

Deenonpoe R, Mairiang E, Mairiang P, Pairojkul C, Chamgramol Y, Rinaldi G, Loukas A, Brindley PJ, Sripa B.

Sci Rep. 2017 Feb 15;7:42744. doi: 10.1038/srep42744.

30.

Patterns of Recurrence after Resection of Mass-Forming Type Intrahepatic Cholangiocarcinomas

Luvira V, Eurboonyanun Ch, Bhudhisawasdi V, Pugkhem A, Pairojkul Ch, Luvira V, Sathitkarnmanee E, Somsap K, Kamsa-ard S.

Asian Pac J Cancer Prev. 2016 Oct 1;17(10):4735-4739.

31.

Plasma orosomucoid 2 as a potential risk marker of cholangiocarcinoma.

Rucksaken R, Charoensuk L, Pinlaor P, Pairojkul C, Khuntikeo N, Pinlaor S.

Cancer Biomark. 2017;18(1):27-34. doi: 10.3233/CBM-160670.

PMID:
27814272
32.

Cytokine profiles in Opisthorchis viverrini stimulated peripheral blood mononuclear cells from cholangiocarcinoma patients.

Surapaitoon A, Suttiprapa S, Khuntikeo N, Pairojkul C, Sripa B.

Parasitol Int. 2017 Feb;66(1):889-892. doi: 10.1016/j.parint.2016.10.009. Epub 2016 Oct 18.

33.

MR imaging findings of a patient with isolated intrahepatic splenosis mistaken for hepatocellular carcinoma.

Somsap K, Chamadol N, Titapun A, Pairojkul C, Sangkhamanon S.

BJR Case Rep. 2016 Sep 29;3(1):20150242. doi: 10.1259/bjrcr.20150242. eCollection 2017.

34.

Tissue Microbiome Profiling Identifies an Enrichment of Specific Enteric Bacteria in Opisthorchis viverrini Associated Cholangiocarcinoma.

Chng KR, Chan SH, Ng AHQ, Li C, Jusakul A, Bertrand D, Wilm A, Choo SP, Tan DMY, Lim KH, Soetinko R, Ong CK, Duda DG, Dima S, Popescu I, Wongkham C, Feng Z, Yeoh KG, Teh BT, Yongvanit P, Wongkham S, Bhudhisawasdi V, Khuntikeo N, Tan P, Pairojkul C, Ngeow J, Nagarajan N.

EBioMedicine. 2016 Jun;8:195-202. doi: 10.1016/j.ebiom.2016.04.034. Epub 2016 May 6.

35.

Long-term outcome of surgical resection for intraductal papillary neoplasm of the bile duct.

Luvira V, Pugkhem A, Bhudhisawasdi V, Pairojkul C, Sathitkarnmanee E, Luvira V, Kamsa-Ard S.

J Gastroenterol Hepatol. 2017 Feb;32(2):527-533. doi: 10.1111/jgh.13481.

PMID:
27356284
36.

CD44 variant-dependent redox status regulation in liver fluke-associated cholangiocarcinoma: A target for cholangiocarcinoma treatment.

Thanee M, Loilome W, Techasen A, Sugihara E, Okazaki S, Abe S, Ueda S, Masuko T, Namwat N, Khuntikeo N, Titapun A, Pairojkul C, Saya H, Yongvanit P.

Cancer Sci. 2016 Jul;107(7):991-1000. doi: 10.1111/cas.12967. Epub 2016 Jun 20.

37.

Simultaneous Extensive Intraductal Papillary Neoplasm of the Bile Duct and Pancreas: A Very Rare Entity.

Luvira V, Pugkhem A, Tipwaratorn T, Chamgramol Y, Pairojkul C, Bhudhisawasdi V.

Case Rep Surg. 2016;2016:1518707. doi: 10.1155/2016/1518707. Epub 2016 Jan 26.

38.

Clinicopathological Significance of Osteopontin in Cholangiocarcinoma Cases.

Laohaviroj M, Chamgramol Y, Pairojkul C, Mulvenna J, Sripa B.

Asian Pac J Cancer Prev. 2016;17(1):201-5.

39.

Xanthohumol inhibits STAT3 activation pathway leading to growth suppression and apoptosis induction in human cholangiocarcinoma cells.

Dokduang H, Yongvanit P, Namwat N, Pairojkul C, Sangkhamanon S, Yageta MS, Murakami Y, Loilome W.

Oncol Rep. 2016 Apr;35(4):2065-72. doi: 10.3892/or.2016.4584. Epub 2016 Jan 21.

PMID:
26794001
40.

High glucose enhances progression of cholangiocarcinoma cells via STAT3 activation.

Saengboonmee C, Seubwai W, Pairojkul C, Wongkham S.

Sci Rep. 2016 Jan 8;6:18995. doi: 10.1038/srep18995.

41.

Nanoencapsulated curcumin and praziquantel treatment reduces periductal fibrosis and attenuates bile canalicular abnormalities in Opisthorchis viverrini-infected hamsters.

Charoensuk L, Pinlaor P, Wanichwecharungruang S, Intuyod K, Vaeteewoottacharn K, Chaidee A, Yongvanit P, Pairojkul C, Suwannateep N, Pinlaor S.

Nanomedicine. 2016 Jan;12(1):21-32. doi: 10.1016/j.nano.2015.10.005. Epub 2015 Nov 2.

PMID:
26542278
42.

The miRNAome of Opisthorchis viverrini induced intrahepatic cholangiocarcinoma.

Peng J, Feng Y, Rinaldi G, Yonglitthipagon P, Easley SE, Laha T, Pairojkul C, Bhudhisawasdi V, Sripa B, Brindley PJ, Mulvenna JP, Bethony JM, Plieskatt JL.

Genom Data. 2014 Aug 28;2:274-9. doi: 10.1016/j.gdata.2014.08.007. eCollection 2014 Dec.

43.

Upregulation of 14-3-3 eta in chronic liver fluke infection is a potential diagnostic marker of cholangiocarcinoma.

Haonon O, Rucksaken R, Pinlaor P, Pairojkul C, Chamgramol Y, Intuyod K, Onsurathum S, Khuntikeo N, Pinlaor S.

Proteomics Clin Appl. 2016 Mar;10(3):248-56. doi: 10.1002/prca.201500019. Epub 2015 Dec 15.

PMID:
26435198
44.

Pathological characteristics of intraductal polypoid neoplasms of bile ducts in Thailand.

Nitta T, Nakanuma Y, Sato Y, Hirano S, Pairojkul C.

Int J Clin Exp Pathol. 2015 Jul 1;8(7):8284-90. eCollection 2015.

45.

Altered Expression of Oxidative Metabolism Related Genes in Cholangiocarcinomas.

Aukkanimart R, Boonmars T, Juasook A, Sriraj P, Boonjaraspinyo S, Wu Z, Laummuanwai P, Pairojkul C, Khuntikeo N, Rattanasuwan P.

Asian Pac J Cancer Prev. 2015;16(14):5875-81.

46.

Levels of 8-OxodG Predict Hepatobiliary Pathology in Opisthorchis viverrini Endemic Settings in Thailand.

Saichua P, Yakovleva A, Kamamia C, Jariwala AR, Sithithaworn J, Sripa B, Brindley PJ, Laha T, Mairiang E, Pairojkul C, Khuntikeo N, Mulvenna J, Sithithaworn P, Bethony JM.

PLoS Negl Trop Dis. 2015 Jul 31;9(7):e0003949. doi: 10.1371/journal.pntd.0003949. eCollection 2015.

47.

MRI and (1)H MRS findings of hepatobilary changes and cholangiocarcinoma development in hamsters infected with Opisthorchis viverrini and treated with N-nitrosodimethylamine.

Hanpanich P, Pinlaor S, Charoensuk L, Yongvanit P, Chamgramol Y, Pairojkul C, Mairiang E.

Magn Reson Imaging. 2015 Nov;33(9):1146-1155. doi: 10.1016/j.mri.2015.06.022. Epub 2015 Jun 25.

PMID:
26117689
48.

A microRNA profile associated with Opisthorchis viverrini-induced cholangiocarcinoma in tissue and plasma.

Plieskatt J, Rinaldi G, Feng Y, Peng J, Easley S, Jia X, Potriquet J, Pairojkul C, Bhudhisawasdi V, Sripa B, Brindley PJ, Bethony J, Mulvenna J.

BMC Cancer. 2015 Apr 23;15:309. doi: 10.1186/s12885-015-1270-5.

49.

Quantitative changes in tumor-associated M2 macrophages characterize cholangiocarcinoma and their association with metastasis.

Thanee M, Loilome W, Techasen A, Namwat N, Boonmars T, Pairojkul C, Yongvanit P.

Asian Pac J Cancer Prev. 2015;16(7):3043-50.

50.

Plasma IgG autoantibody against actin-related protein 3 in liver fluke Opisthorchis viverrini infection.

Rucksaken R, Haonon O, Pinlaor P, Pairojkul C, Roytrakul S, Yongvanit P, Selmi C, Pinlaor S.

Parasite Immunol. 2015 Jul;37(7):340-8. doi: 10.1111/pim.12188.

Supplemental Content

Loading ...
Support Center